RecallGuide.ca
    Health productsUpdated Jan 3, 2026JAMPOfficial source

    JAMP-Pregabalin recall in Canada: May contain incorrect dosage

    Share:

    In plain language

    This recall involves one lot of JAMP-Pregabalin 50mg capsules sold in Canada. It's being recalled because some bottles may contain 150mg capsules instead of 50mg. Stop using the product and follow the return steps in the official notice.

    What to do

    • Check your medication bottle to ensure it only contains 50 mg capsules.
    • If it contains any 150 mg capsules, or if you are unsure, return it to your pharmacy immediately.
    • Do not stop taking pregabalin without first speaking to your doctor.
    • Seek immediate medical attention if you experience symptoms of an overdose.

    Get alerts for recalls like this

    Get email alerts when new recalls affect products in this category.

    Categories (optional)

    No spam. Unsubscribe anytime. We only email when there's a relevant recall.

    Affected products

    • JAMP-Pregabalin 50mg Capsules

      Lot: 2305012747

    Why this matters

    Incorrect dosage risk

    Do I have this product?

    This recall only applies to specific products. Follow the steps below to check.

    1. 1

      Check the product name

      Make sure your product name matches one of the affected products listed above.

    2. 2

      Check the lot number

      Lot numbers identify specific production batches.

      Affected lots: 2305012747

    If your product matches one or more of the details above, it may be affected by this recall.

    If your product does not match these details, it is not affected by this recall.

    When in doubt, always check the official notice.

    Want alerts if similar products are recalled in Canada?

    Frequently Asked Questions

    Why was this product recalled?

    Incorrect dosage risk

    What should consumers do?

    Check your medication bottle to ensure it only contains 50 mg capsules. If it contains any 150 mg capsules, or if you are unsure, return it to your pharmacy immediately. Do not stop taking pregabalin without first speaking to your doctor. Seek immediate medical attention if you experience symptoms of an overdose.

    Where was the product sold?

    This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.

    Is there a health risk?

    Yes, there may be a health risk. Incorrect dosage risk

    When was this product recalled?

    This product was recalled on May 5, 2025.

    Is the JAMP brand affected by this recall?

    Yes, JAMP products are affected by this recall. This recall involves one lot of JAMP-Pregabalin 50mg capsules sold in Canada. It's being recalled because some bottles may contain 150mg capsules instead of 50mg. Stop using the product and follow the return steps in the official notice.